Cargando…

Sequential Cohort Design Applying Propensity Score Matching to Analyze the Comparative Effectiveness of Atorvastatin and Simvastatin in Preventing Cardiovascular Events

BACKGROUND: Sequential cohort design (SCD) applying matching for propensity scores (PS) in accrual periods has been proposed to mitigate bias caused by channeling when calendar time is a proxy for strong confounders. We studied the channeling of patients according to atorvastatin and simvastatin ini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helin-Salmivaara, Arja, Lavikainen, Piia, Aarnio, Emma, Huupponen, Risto, Korhonen, Maarit Jaana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948677/ https://www.ncbi.nlm.nih.gov/pubmed/24614626 http://dx.doi.org/10.1371/journal.pone.0090325

Ejemplares similares

Accumulation of Cardiovascular and Diabetes Medication among Apparently Healthy Statin Initiators
por: Lavikainen, Piia, et al.
Publicado: (2015)

Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence
por: Lavikainen, Piia, et al.
Publicado: (2016)

Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland
por: Ruokoniemi, Päivi, et al.
Publicado: (2014)

Correction: Sequential Cohort Design Applying Propensity Score Matching to Analyze the Comparative Effectiveness of Atorvastatin and Simvastatin in Preventing Cardiovascular Events
Publicado: (2014)

Statins and Hip Fracture Prevention – A Population Based Cohort Study in Women
por: Helin-Salmivaara, Arja, et al.
Publicado: (2012)

Change in antihypertensive drug prescribing after guideline implementation: a controlled before and after study
por: Sipilä, Raija, et al.
Publicado: (2011)

Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study
por: Aarnio, Emma, et al.
Publicado: (2023)

Natural history of bleeding and characteristics of early bleeders among warfarin initiators – a cohort study in Finland
por: Rikala, Maria, et al.
Publicado: (2016)

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
por: Jalkanen, Kari, et al.
Publicado: (2021)

Impact of missing data mechanism on the estimate of change: a case study on cognitive function and polypharmacy among older persons
por: Lavikainen, Piia, et al.
Publicado: (2015)

Atorvastatin and simvastatin as analgesic agents in experimental models
por: Dwajani, S., et al.
Publicado: (2012)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
por: Jaiswal, Swapnil R., et al.
Publicado: (2012)

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population
por: Jalkanen, Kari, et al.
Publicado: (2019)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2020)

Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin
por: Hauta-aho, Milka, et al.
Publicado: (2020)

CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand
por: Rattanachotphanit, Thananan, et al.
Publicado: (2019)

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2022)

Predictors of first-year statin medication discontinuation: A cohort study
por: Halava, Heli, et al.
Publicado: (2016)

Evaluation of Sexual Dimorphism in the Efficacy and Safety of Simvastatin/Atorvastatin Therapy in a Southern Brazilian Cohort
por: Smiderle, Lisiane, et al.
Publicado: (2014)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Sivkov, Andrey, et al.
Publicado: (2021)

Amount of external CME in groups of specialties: a nation-wide survey among Finnish doctors
por: Helin-Salmivaara, Arja, et al.
Publicado: (2009)

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
por: Bally, Michèle, et al.
Publicado: (2017)

Disparate Effects of Atorvastatin Compared With Simvastatin on C-Reactive Protein Concentrations in Patients With Type 2 Diabetes
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort
por: Clarke, Alan T., et al.
Publicado: (2016)

Antiepileptic Drug Use and the Risk of Stroke Among Community‐Dwelling People With Alzheimer Disease: A Matched Cohort Study
por: Sarycheva, Tatyana, et al.
Publicado: (2018)

Applied comparison of large‐scale propensity score matching and cardinality matching for causal inference in observational research
por: Fortin, Stephen P., et al.
Publicado: (2021)

Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland
por: Martikainen, Janne, et al.
Publicado: (2021)

Locally applied Simvastatin improves fracture healing in mice
por: Skoglund, Björn, et al.
Publicado: (2007)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
por: Gandhi, Sanjay K, et al.
Publicado: (2012)

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
por: Insull, William, et al.
Publicado: (2010)

Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern
por: Eliasson, Pernilla, et al.
Publicado: (2017)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Similar Medication Compliance and Control of Dyslipidemia WithSimvastatin or Atorvastatin in a Staff-Model HMO Medical Clinic
por: Valdez, Connie A., et al.
Publicado: (2005)

Correction to: Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research
por: Fortin, Stephen P., et al.
Publicado: (2021)

Agreement between physician- and patient-reported Canadian cardiovascular society scores among patients undergoing elective coronary angiography–The CATS study
por: Lavikainen, Piia, et al.
Publicado: (2023)

Systemic Estrogen Use and Discontinuation After Alzheimer’s Disease Diagnosis in Finland 2005–2012: A Nationwide Exposure-Matched Cohort Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4kg5uelhg89npquc2ifug7qdgg